Lack of pharmacokinetic interaction between cefepime and amikacin in humans.
The interaction potential between cefepime and amikacin was investigated in a steady-state pharmacokinetic study in 16 healthy male subjects. Eight subjects (group A) received a first course of 2,000 mg of cefepime; this was followed by a second course of 2,000 mg of cefepime with 300 mg of amikacin...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1992
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191590/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1510431/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.7.1382 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|